Skip to Content

GG 706 (Ranitidine Hydrochloride 300 mg)

Pill with imprint GG 706 is Orange, Round and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; gerd; duodenal ulcer prophylaxis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 706

Ranitidine hydrochloride 300 mg GG 706
Ranitidine hydrochloride 300 mg GG 706  Front
Ranitidine hydrochloride 300 mg GG 706  Back
Ranitidine hydrochloride 300 mg GG 706

Ranitidine Hydrochloride

Imprint
GG 706
Strength
300 mg
Color
Orange
Size
11.00 mm
Shape
Round
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC)
00781-1884
Inactive Ingredients
D&C Red No. 30, D&C Yellow No. 10, hydroxypropyl cellulose (type h), hypromellose 2910 (3 mPa.s), magnesium stearate, microcrystalline cellulose, peppermint, sodium starch glycolate type A potato, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.